Blood transfusion and iatrogenic risks in Mexico city: anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive
Hernández-Becerril, Nidia, Mejía, Ana Maria, Ballinas-Verdugo, Martha Alicia, Garza-Murillo, Verónica, Manilla-Toquero, Elsa, López, Ruth, Trevethan, Sergio, Cardenas, Manuel, Reyes, Pedro Antonio, Hirayama, Kenji, Monteón, Victor Manuel
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
Iatrogenous transmission of Trypanosoma cruziby blood transfusion was suggested as a potential risk by Pellegrino (1949). Seropositive blood donors in Mexico were first reported in 1978, however, limited information is available due to small sampling, the use of heterogeneous serologic assays, and geographically limited studies. A wide survey carried out in 18 out of the 32 states of Mexico, showed a national mean of 1.6% seropositive among 64,969 donors, ranging from 0.2 to 2.8%. In the present study, we have screened 43,048 voluntary blood donors in a period of five years at the Instituto Nacional de Cardiología I. Chávez, a concentration hospital located in Mexico city which serves mainly the metropolitan area and accepts from all over the country. Standardized ELISA and IIF were used to identify seropositive individuals in addition to hemoculture, PCR and standard 12 lead ECG tests that were applied to a group of seropositive patients (29/161). The result showed a seropositivity of 0.37% (161/43,048). From the group of seropositive individuals 40% (12/29) were potential carriers of T. cruzi at the donation time and 5/29 had subclinical ECG abnormalities. Parasitological tests performed in 70 erythrocyte and platelet fractions from seropositive units (70/161) showed negative results. Our findings strongly support T. cruzi screening in the transfusion medicine practice and identify subclinical heart disease among seropositive blood donors.
- Anti-Trypanosoma cruzi antibody detection in blood donors in the Southern Brazil
- Anti-Trypanosoma cruzi inconclusive results in blood donor screening
- High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico
- Induction of capping in blood-stage trypomastigotes of Trypanosoma cruzi by human anti-Trypanosoma cruzi antibodies.
- Avaliação in vivo da atividade anti-Trypanosoma cruzi de derivados nitroimidazólicos